Skip to main content
Clinical Trials/NCT00292812
NCT00292812CompletedNot Applicable

The Clinical Effects of an Infant Formula Supplemented With Various Concentrations of Nucleotides

Soroka University Medical Center1 site in 1 country150 target enrollmentStarted: March 1, 2006Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
150
Locations
1
Primary Endpoint
Growth percentiles, Behaviour and infantile colic, Bowel habits.

Study Overview

Brief Summary

The study hypothesis is that different concentrations of nucleotides' supplementation of an infant formula might affect differently growth and/or other clinical parameters in neonates.

Detailed Description

Three groups of 50 newborn infants each, will be fed for 30 days an infant formula supplemented with either 4.9 mg/100 kcal or 10.6 mg/100 kcal of nucleotides or with no supplementation. Newborns will be monitored prospectively for the following outcome parameters:

  • Growth percentiles.
  • Behaviour and infantile colic.
  • Bowel habits.
  • Side effects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double

Eligibility Criteria

Ages
1 Day to 30 Days (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy newborns aged 0-30 days.

Exclusion Criteria

  • •Prematurity
  • •Chronic illness
  • •Failure to thrive
  • •Milk allergy

Outcomes

Primary Outcomes

Growth percentiles, Behaviour and infantile colic, Bowel habits.

Secondary Outcomes

  • Side effects.

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials